NIH seeks public comment on draft clinical trial protocol template

In an effort to make it easier for investigators to prepare protocols that are consistently organized and contain all the information necessary for the clinical trial to be properly reviewed, the NIH and FDA are developing a template with instructional and sample text for NIH-funded investigators to use in writing protocols for phase 2 or 3 clinical trials that require applications for Investigational New Drugs (INDs) or Investigational Device Exemptions (IDEs). They would like you to weigh in on the template.

Comments on the draft template from investigators, investigator-sponsors, and institutional review board members, and any other stakeholders who are involved in protocol development and review can be submitted here through April 17, 2016. Perspectives on the utility of such a template and whether the instructional and sample text is clear and readable are of particular interest.

Bookmark and Share

Comments are closed.

About the Author

Julie Rogers is Research Development Associate in the Office of Research Funding & Development Services.

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives